Antibody to very late activation antigen 4 prevents interleukin-5-induced airway hyperresponsiveness and eosinophil infiltration in the airways of guinea pigs

Journal of Allergy and Clinical Immunology

Volumn 100, Issue 2, 1997, Pages 242-250

  Kraneveld, Aletta D ^a   Van Ark, Ingrid ^a   Van Der Linde, Henk J ^a   Fattah, Dilniya ^b   Nijkamp, Frans P ^a   Van Oosterhout, Antoon J M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Airway hyperresponsiveness; Eosinophil; Lnterleukin 5; Very late activation antigen 4

Indexed keywords

ANIMAL TISSUE; ANTIGEN ANTIBODY REACTION; ARTICLE; ASTHMA; BRONCHUS REACTIVITY; CELL INFILTRATION; EOSINOPHIL; GUINEA PIG; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; EOSINOPHILIA; EOSINOPHILS; GUINEA PIGS; INTEGRIN ALPHA4BETA1; INTEGRINS; INTERLEUKIN-5; LEUKOCYTES; LUNG; MALE; RECEPTORS, LYMPHOCYTE HOMING;

EID: 0030842333     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70231-8     Document Type: Article

References (44)

1. O'Byrne PM. Allergen-induced airway hyperresponsiveness. J Allergy Clin Immunol 1988;81:119-27.
2. Kay AB. Asthma and inflammation. J Allergy Clin Immunol 1991; 87:893-910.
3. Van Oosterhout AJM, Nijkamp FP. Minireview: lymphocytes and bronchial hyperresponsiveness. Life Sci 1990;46:1255-64.
4. Garssen J, Nijkamp FP, Van der Vliet H, Van Loveren H. T-cell mediated induction of airway hyperreactivity in mice. Am Rev Respir Dis 1991;144:931-8.
5. Gerblich AA, Salik H, Schuyler MR. Dynamic T-cell changes in peripheral blood and bronchoalveolar lavage after antigen bronchoprovocation in asthmatics. Am Rev Respir Dis 1991;143:533-7.
6. Hamid Q, Azzawi M, Ying S, et al. Expression of messenger RNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991;87:1541-6.
7. Kay AB, Ying S, Varney V, et al. Messenger RNA expression of the cytokine gene cluster, interleukin-3 (IL-3), IL-4, IL-5, and granulocyte macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med 1991;173: 775-8.
8. Robinson DS, Hamid Q, Ying S, et al. Predominant Th2-like bronchoalveolar T-iymphocyte population in atopic asthma. New Engl J Med 1992;326:298-304.
9. Migita M, Yamaguchi N, Mita S, et al. Characterization of human lL5-receptors on eosinophils. Cell Immunol 1991;133:484-97.
10. Clutterbuck EJ, Hirst EMA, Sanderson CJ. Human interleukin-5 (IL-5) regulates the production of eosinophil in human bone marrow cultures: Comparison and interaction with IL-1, IL-3, IL-6, and GM-CSF. Blood 1989;73:1504-12.
11. Sanderson CJ. Interleukin-5, eosinophils, and disease. Blood 1992; 79:3101-9.
12. Walsh GM, Hartnell A, Wardlaw AJ, Kurihara K, Sanderson CJ, Kay AB. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. Immunology 1990;71:258-65.
13. Wang JM, Rambaldi A, Biondi A, Chen ZG, Sanderson CJ, Mantovani A. Recombinant human interleukin-5 is a selective eosinophil chemoattractant. Eur J Immunol 1989;19:701-5.
14. Van Oosterhout AJM, Van der Poel A, Koenderman L, Roos D, Nijkamp FP. Interleukin-5 potentiates sulfidopeptide leukotriene production by human eosinophils. Med Inflam 1994;3:53-6.
15. Warringa RAJ. Schweizer RC, Maikoe T, Kuijper PHM, Bruijnzeel PLB, Koenderman L. Modulation of eosinophil chemotaxis by interleukin-5. Am J Respir Cell Mol Biol 1992;7:631-6.
16. Fujisawa T, Abu-Ghazaleh R, Kita H, Sanderson CJ, Gleich GJ. Regulatory effect of cytokines on eosinophil degranulation. J Immunol 1990;144:642-6.
17. Lopez AF, Sanderson CJ, Gamble JR, Campbell HR, Young IG, Vadas MA. Recombinant human interleukin-5 is a selective activator of human eosinophil function. J Exp Med 1988;167:219-24.
18. Van Oosterhout AJM, Ladenius ARC, Savelkoul HFJ, Van Ark I, Delsman KC, Nijkamp FP. Effect of anti-lL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. Am Rev Respir Dis 1993;147:548-52.
19. Mauser PJ, Pitman A, Win A, et al. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. Am Rev Respir Dis 1993;148:1623-7.
20. Van Oosterhout AJM, van Ark I, Hofman G, Savelkoul HFJ, Nijkamp FP. Recombinant interleukin-5 induces in vivo airway hyperresponsiveness to histamine in guinea pigs. Eur J Pharmacol 1993;236:379-83.
21. Van Oosterhout AJM, Fattah D, Van Ark I, Hofman G, Buckley TL, Nijkamp FP. Eosinophil infiltration precedes development of airway hyperreactivity and mucosal exudation after intranasal administration of interleukin-5 to mice. J Allergy Clin Immunol 1995;96:104-12.
22. Nakajima H, Sano H, Nishimura T, Yoshida S. Iwamoto I. Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in allergen-induced eosinophil and T cell recruitment into the tissue. J Exp Med 1994;179:1145-54.
23. Weg VB, Williams TH, Lobb RR, Nourshargh S. A monoclonal antibody recognizing very late activation antigen-4 inhibits eosinophil accumulation in vivo. J Exp Med 1993;177:561-6.
24. Schleimer RP, Sterbinsky SA, Kaiser J, et al. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J Immunol 1992;148: 1086-92.
25. Weller PF, Rand TH, Goelz SE, Chi-Rosso G, Lobb RR. Human eosinophil adherence to vascular endothelium mediated by binding to vascular cell adhesion molecule 1 and endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci U S A 1991;88:7403-33.
26. Fattah D, Bezbarauh S, Solari R. Effects of interleukin-5 on eosinophil adhesion molecules. Am Rev Respir Dis 1994;149:A834.
27. Dobrina A, Menegazzi R, Carlos TM, et al. Mechanisms of eosinophil adherence to cultured vascular endothelial cells - eosinophils bind to the cytokine-induced endothelial ligand vascular cell adhesion molecule-1 via the very late activation antigen 4 integrin receptor. J Clin Invest 1991;88:20-6.
28. Ohkawara Y, Yamauchi K, Maruyama N, et al. In situ expression of the cell adhesion molecules in bronchial tissues from asthmatics with air flow limitation: in vivo evidence of VCAM-1/VLA-4 interaction in selective eosinophil infiltration. Am J Respir Cell Mol Biol 1995;12:4-12.
29. Pretolani M, Ruffle C, Lapa e Silva J-R, Joseph D, Lobb RR, Vargaftig BB. Antibody to very late activation antigen 4 prevents antigen-induced bronchial hyperreactivity and cellular infiltration in guinea pig airways. J Exp Med 1994;180:795-805.
30. Pulido R, Elices MJ, Campanero MR, et al. Functional evidence for three distinct and independently inhibitable adhesion activities mediated by the human integrin VLA-4. J Biol Chem 1991;266:10241-5.
31. Amdur MO, Mead J. Mechanics of respiration in unanesthetized guinea pigs. Am J Physiol 1957;192:364-8.
32. Strath M, Warren DJ, Sanderson CJ. Detection of eosinophils using an eosinophil peroxidase assay. Its use as an assay for eosinophil differentiation factors. J Immunol Methods 1985;83:209-15.
33. Van Oosterhout AJM, van Ark I, Hofman G, van der Linde HJ, Fattah D, Nijkamp FP. Role of interleukin-5 and substance P in the development of airway hyperreactivity to histamine in guinea pigs. Eur Respir J 1996;9:493-9.
34. Sibille Y, Reynolds HY. Macrophage and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 1990;141: 471-501.
35. Pretolani M, Ruffle C, Joseph D, et al. Role of eosinophil activation in the bronchial reactivity of allergic guinea pigs. Am J Respir Crit Care Med 1194;149:1167-74.
36. Coffman RL, Seymour BWP, Hudak S, Jackson J, Rennick D. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 1988;245:308-10.
37. Pretolani M, Lefort J, Leduc D, Vargaftig BB. Effect of human recombinant interleukin-5 on in vitro responsiveness to PAF of lung from actively sensitized guinea pigs. Br J Pharmacol 1992;106:677-84.
38. Walsh GM, Wardlaw AJ, Hartnell A, Sanderson CJ, Kay AB. Interleukin-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leukocyte integrin (CD11/18)-dependent manner. Int Arch Allergy Immunol 1991;94:174-8.
39. Neeley SP, Hamann KJ, White SR, Baranowski SL, Burch RA, Leff AR. Selective regulation of expression of surface adhesion molecules Mac-1, L-selectin and VLA-4 on human eosinophils and neutrophils. Am J Respir Cell Mol Biol 1992;8:633-9.
40. Das AM, Williams TJ, Lobb RR, Nourshargh S. Lung eosinophilia is dependent on IL-5 and the adhesion molecules CD18 and VLA-4, in a guinea-pig model. Immunology 1995;84:41-6.
41. Teixaira MM, Williams TJ, Hellewell PG. Mechanisms and pharmacological manipulation of eosinophil accumulation in vivo. Trends Pharmacol Sci 1995;16:418-23.
42. Corrigan CJ, Kay AB. T cells and eosinophils in the pathogenesis of asthma. Immunol Today 1992;13:501-6.
43. Horie S, Kita H. CD11b/CD18 (MAC-10) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet-activating factor. J Immunol 1994;152:5457-67.
44. 1 (VLA-4). Immunology 1994;82:222-8.